A new KLF13 loss-of-function mutation responsible for sporadic dilated cardiomyopathy

Area of Science:

• Cardiovascular Genetics
• Molecular Cardiology
• Genetic Basis of Heart Disease

Background:

• KLF13 mutations are known to cause familial dilated cardiomyopathy (DCM).
• The prevalence and spectrum of KLF13 mutations in sporadic DCM cases were previously unexplored.
• Understanding genetic factors in sporadic DCM is crucial for diagnosis and treatment.

Purpose of the Study:

• To identify novel KLF13 mutations associated with sporadic DCM.
• To investigate the functional consequences of identified KLF13 mutations.
• To elucidate the role of KLF13 in the molecular pathogenesis of DCM.

Main Methods:

• Sequencing of the KLF13 gene in 212 sporadic DCM patients and 256 healthy controls.
• Clinical investigation of affected individuals.
• Dual-luciferase reporter assays to assess the functional impact of KLF13 mutations on target genes (ACTC1, MYH7, ANP).

Main Results:

• A novel heterozygous truncating KLF13 mutation (NM_015995.3:c.534C>G;p.(Tyr178*)) was identified in two unrelated sporadic DCM patients.
• This mutation was absent in the control group.
• The Tyr178* mutant KLF13 protein demonstrated reduced transactivation of ACTC1 and MYH7, and impaired synergistic transactivation of ANP with GATA4.

Conclusions:

• KLF13 is implicated as a novel gene predisposing to sporadic DCM.
• The findings enhance understanding of DCM's molecular pathology.
• This research may inform personalized prevention and treatment strategies for DCM patients.